Skip to main content

Advertisement

Log in

Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India

  • Original Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Hepatitis E virus (HEV) is transmitted primarily through contaminated water and food. Recently, HEV viremia in blood donors and transfusion-related transmission of HEV have been reported, leading to calls to screen donated blood for this virus. However, these data are from regions where genotype 3 HEV is predominant. In India, where human infections are caused only by genotype 1 HEV, the frequency of subclinical HEV viremia is unknown.

Methods

Minipools of sera prepared from three donor units each from our institution's  blood bank in Lucknow, India, were tested for HEV RNA using a sensitive amplification-based assay. A randomly selected subset was also tested for IgG anti-HEV antibodies using a commercial (Wantai) immunoassay.

Results

Sera from 1799 donors (median [range] age 30 [18–63] years; 1746 [97.0%] men) were collected (June–July 2016, 900; November–December 2016, 899). Of these, 17 (0.95%), 16 (0.90%), and 3 (0.17%) tested positive for HBsAg, anti-HCV, and anti-HIV antibodies, respectively. None of the donors tested positive for HEV RNA. Of 633 randomly selected donors (age 30 [18–63] years, 613 [96.8%] male) tested for IgG anti-HEV, 383 (60.5%) tested positive. Seropositivity rate increased with age, being 70/136 (52%), 177/299 (59%), 100/154 (65%), 30/34 (88%), and 6/10 (60%) in the 18–24, 25–34, 35–44, 45–54, and 55 years or older age groups, respectively.

Conclusions

In healthy blood donors from northern India, HEV viremia is infrequent though anti-HEV antibody prevalence is high. This suggests that asymptomatic HEV viremia may be less frequent in areas with genotype 1 predominance than those with genotype 3 predominance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Goel A, Aggarwal R. Advances in hepatitis E - II: epidemiology, clinical manifestations, treatment and prevention. Expert Rev Gastroenterol Hepatol. 2016;10:1065–74.

    Article  CAS  PubMed  Google Scholar 

  2. Lee GH, Tan BH, Teo EC, et al. Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology. 2016;150:355–7. e3

    Article  PubMed  Google Scholar 

  3. Donnelly MC, Scobie L, Crossan CL, Dalton H, Hayes PC, Simpson KJ. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther. 2017;46:126–41.

    Article  CAS  PubMed  Google Scholar 

  4. Aggarwal R, Jameel S. Hepatitis E. Hepatology. 2011;54:2218–26.

    Article  PubMed  Google Scholar 

  5. Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992;70:597–604.

  6. Dalton HR, Izopet J. Transmission and epidemiology of hepatitis E virus genotype 3 and 4 infections. Cold Spring Harbor Perspect Med. 2018. pii: a032144.

  7. Kamar N, Izopet J, Pavio N, et al. Hepatitis E virus infection. Nat Rev Dis Primers. 2017;3:17086.

    Article  PubMed  Google Scholar 

  8. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384:1766–73.

    Article  Google Scholar 

  9. Al-Sadeq DW, Majdalawieh AF, Nasrallah GK. Seroprevalence and incidence of hepatitis E virus among blood donors: a review. Rev Med Virol. 2017;27 https://doi.org/10.1002/rmv.1937.

    Article  Google Scholar 

  10. Petrik J, Lozano M, Seed CR, et al. Hepatitis E. Vox Sang. 2016;110:93–103.

  11. Pawlotsky JM. Hepatitis E screening for blood donations: an urgent need? Lancet. 2014;384:1729–30.

    Article  Google Scholar 

  12. Domanovic D, Tedder R, Blumel J, et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? Euro Surveill. 2017;22:30514.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kumar N, Sarin SK. Hepatitis E- is it a risk to transfusion safety? Asian J Transfus Sci. 2013;7:1–3.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Aggarwal R, Goel A. Screening transfusions for hepatitis E virus: is it needed in India? Natl Med J India. 2015;28:217–9.

    PubMed  Google Scholar 

  15. Arankalle VA, Chobe LP. Hepatitis E virus: can it be transmitted parenterally? J Viral Hepat. 1999;6:161–4.

    Article  CAS  PubMed  Google Scholar 

  16. Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol. 2004;19:778–84.

    Article  PubMed  Google Scholar 

  17. Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang. 2000;79:72–4.

    Article  CAS  PubMed  Google Scholar 

  18. Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods. 2006;131:65–71.

    Article  CAS  PubMed  Google Scholar 

  19. Minagi T, Okamoto H, Ikegawa M, et al. Hepatitis E virus in donor plasma collected in Japan. Vox Sang. 2016;111:242–6.

    Article  CAS  PubMed  Google Scholar 

  20. Baylis SA, Gartner T, Nick S, Ovemyr J, Blumel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang. 2012;103:89–90.

    Article  CAS  PubMed  Google Scholar 

  21. Arankalle VA, Tsarev SA, Chadha MS, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis. 1995;171:447–50.

    Article  CAS  PubMed  Google Scholar 

  22. Gupta BP, Lama TK, Adhikari A, et al. First report of hepatitis E virus viremia in healthy blood donors from Nepal. Virusdisease. 2016;27:324–6.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Gupta N, Sarangi AN, Dadhich S, et al. Acute hepatitis E in India appears to be caused exclusively by genotype 1 hepatitis E virus. Indian J Gastroenterol. 2018;37:44–9.

    Article  PubMed  Google Scholar 

  24. Singh A, Seth R, Gupta A, et al. Chronic hepatitis E - an emerging disease in an immunocompromised host. Gastroenterol Rep (Oxf). 2016. pii: gow024.

  25. Naik A, Gupta N, Goel D, Ippagunta SK, Sharma RK, Aggarwal R. Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J Viral Hepat. 2013;20:e138–40.

    Article  CAS  PubMed  Google Scholar 

  26. Munjal S, Gupta N, Sharma RK, et al. Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India. Indian J Gastroenterol. 2014;33:550–3.

    Article  PubMed  Google Scholar 

  27. Agarwala P, Gupta E, Choudhary MC, Pamecha V. Absence of chronic hepatitis E virus infection in liver transplant recipients: report from a hyperendemic region. Indian J Gastroenterol. 2018;37:160–3.

    Article  PubMed  Google Scholar 

  28. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82:799–805.

    Article  CAS  PubMed  Google Scholar 

  29. Zhang J, Zhang XF, Huang SJ, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015;372:914–22.

Download references

Funding

This work was supported by an intramural research grant from the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, to RA. HK was supported by a grant from the Department of Biotechnology, Government of India.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rakesh Aggarwal.

Ethics declarations

Conflict of interest

HK, AG, AS, VY, SS, RC, and RA declare that they have no conflict of interest.

Informed consent

Written informed consent was taken from all the subjects.

Ethics statement

The authors declare that the study was performed in a manner to conform with the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.

Disclaimer

The authors are solely responsible for the findings and the content of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members and the printer/publishers are responsible for the results/findings and the content of this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katiyar, H., Goel, A., Sonker, A. et al. Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India. Indian J Gastroenterol 37, 342–346 (2018). https://doi.org/10.1007/s12664-018-0880-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-018-0880-7

Keywords

Navigation